Cited by 457Gut microbiota and healthAntibiotic Resistance in BacteriaInfant Nutrition and Health

Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome

Open access
Gibson, Molly K., Wang, Bin, Ahmadi, Sara, Burnham, Carey-Ann D., Tarr, Phillip I., Warner, Barbara B., Dantas, Gautam·2016·Nature Microbiology

Abstract

Development of the preterm infant gut microbiota is emerging as a critical research priority(1). Since preterm infants almost universally receive early and often extended antibiotic therapy(2), it is important to understand how these interventions alter gut microbiota development(3-6). Analysis of 401 stools from 84 longitudinally sampled preterm infants demonstrates that meropenem, cefotaxime and ticarcillin-clavulanate are associated with significantly reduced species richness. In contrast, vancomycin and gentamicin, the antibiotics most commonly administered to preterm infants, have non-uniform effects on species richness, but these can be predicted with 85% accuracy based on the relative abundance of only two bacterial species and two antibiotic resistance (AR) genes at treatment initiation. To investigate resistome development, we functionally selected resistance to 16 antibiotics from 21 faecal metagenomic expression libraries. Of the 794 AR genes identified, 79% had not previously been classified as AR genes. Combined with deep shotgun sequencing of all stools, we find that multidrug-resistant members of the genera Escherichia, Klebsiella and Enterobacter, genera commonly associated with nosocomial infections, dominate the preterm infant gut microbiota. AR genes that are enriched following specific antibiotic treatments are generally unique to the specific treatment and are highly correlated with the abundance of a single species. The most notable exceptions include ticarcillin-clavulanate and ampicillin, both of which enrich for a large number of overlapping AR genes, and are correlated with Klebsiella pneumoniae. We find that all antibiotic treatments are associated with widespread collateral microbiome impact by enrichment of AR genes that have no known activity against the specific antibiotic driver.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nmicrobiol.2016.24

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Enterococcus, Escherichia, and Klebsiella are common nosocomial pathogens and are often implicated in late-onset infections in preterm infants.

    “These findings align with reports from other NICU studies, where Enterococcus, Escherichia, and Klebsiella are common nosocomial pathogens and are often implicated in late-onset infections in preterm infants32,45,46.”

    From Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants. (2025) · cites this paper as [45]

    The Abstract (page unavailable) describes Escherichia and Klebsiella as genera commonly associated with nosocomial infections and lists Enterococcus faecium in the ESKAPE pathogen family. It does not say that these three genera are often implicated in late-onset infections in preterm infants; the study examines their presence in the gut microbiota, not infection incidence. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gibson, M. K., Wang, B., Ahmadi, S., Burnham, C.-A. D., Tarr, P. I., Warner, B. B., & Dantas, G.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Dantas, Gautam
Venue
Nature Microbiology
Published
2016-03-07
Volume
1
Issue
4
Pages
16024-16024
ISSN
2058-5276 (ISSN-L)
OpenAlex
W2331300001
Cited by
457
References
45
Citations by year
2026: 33 · 2025: 44 · 2024: 47 · 2023: 46 · 2022: 59 · 2021: 48 · 2020: 49 · 2019: 50 · 2018: 37 · 2017: 33 · 2016: 11
FWCI
22.56
Type
journal article
Language
en
Open access
Locations
  • Nature Microbiology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR000448)
  • National Institute of General Medical Sciences (R01GM099538)
  • National Institute of Allergy and Infectious Diseases (UH3AI083265)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK052574)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
antibiotic resistome, antibiotic resistance genes, meropenem, cefotaxime, ticarcillin-clavulanic acid, vancomycin, gentamicin, multidrug resistance, Klebsiella pneumoniae, Escherichia, Enterobacter, nosocomial infections
MeSH terms
Gastrointestinal Microbiome, Anti-Bacterial Agents, Genes, Bacterial, Humans, Infant, Premature, Longitudinal Studies, Sequence Analysis, DNA, Drug Resistance, Bacterial, Gastrointestinal Tract

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review